Focused on the development of Innovative Drug Therapies
   
Our Company
Pipeline
Press Room
Contact Us
Acorn Biomedical, Inc. is a development stage biopharmaceutical company focused on the acquisition, in-licensing and development of innovative drug therapies.
T-Fusion-TM Platform 		latest news

April 17, 2009


Acorn acquired a worldwide license from a prestigious university for a novel small molecule for the treatment of glaucoma.

.		  
   
 
     
  ©2009 Acorn Biomedical, Inc.  All Rights Reserved. Acorn Biomedical is a trademark of Acorn Biomedical, Inc.